UCL Institute of Ophthalmology

Please, note that this channel is no longer active. For regular social media updates from the UCL Institute of Ophthalmology, make sure to follow:
- our official LinkedIn Page: https://www.linkedin.com/showcase/ucl-institute-of-ophthalmology/
- our official YouTube channel: https://www.youtube.com/channel/UCGUo7-2_6eYpUVGFfnYOMFQ/featured
- our official BlueSky account: https://bsky.app/profile/ucleye.bsky.social

UCL Institute of Ophthalmology | LinkedIn UCL Institute of Ophthalmology | 6,316 followers on LinkedIn. Part of UCL Faculty of Brain Sciences the IoO leads research and teaching in ophthalmology and biomedical science. | Our researchers are pioneering treatments and trials that have an immediate effect on patients’ lives. Our students lea...

2025 Angle Award - Sir Peng T. Khaw, MD, PhD, FARVO

If you have experience managing multiple complex projects in the NHS or similar organisation, consider joining a high-performing team at the forefront of delivering a brand-new world leading centre for advancing eye health in London. The team is currently looking for two Programme Managers, and a Senior Operational Change Manager:

lnkd.in

Follow us on BlueSky:

UCL Institute of Ophthalmology (@ucleye.bsky.social) We deliver cutting-edge research and teaching in ophthalmology and biomedical science. Part of the UCL Faculty of Brain Sciences.

This January for we are highlighting some of the recently published studies from UCL Institute of Ophthalmology on this important topic.

A study published in Nature Medicine last July asked whether mitochondrial function, measured in white blood cells, is lower in people with glaucoma than those without glaucoma and if mitochondrial function is associated with the rate at which glaucoma patients lose vision. Led by researchers at our institute and at Moorfields Eye Hospital.

Biomarkers reveal how patients with glaucoma may respond to treatment Markers in the blood that predict whether glaucoma patients are at higher risk of continued loss of vision following conventional treatment have been identified by researchers at UCL and Moorfields Eye Hospital.

We are excited to launch our 2023-2024 Annual Review, covering some key highlights from the institute, including special features on research, education, and the vibrant community at UCL Institute of Ophthalmology.

We are seeking a Research Fellow to work in close collaboration with Professor Mariya Moosajee to focus on the development of non-viral approaches, using mRNA and non-viral gene therapy, as potential treatment options for RLBP1-retinopathy.

If you are a good communicator, both in lay and scientific terms, and have background understanding of genetic eye disease, read more details about what the position entails and apply by 5 January.

UCL – University College London UCL is consistently ranked as one of the top ten universities in the world (QS World University Rankings 2010-2022) and is No.2 in the UK for research power (Research Excellence Framework 2021).

Today is a special day on our journey to build a new centre for eye care, research, and education. Later today we will mark reaching the highest point of the new building with a topping out ceremony on the site. The centre is due to open in 2027.

With the façade being installed, our new centre in Camden is really starting to take shape. The centre will bring clinicians, patients and scientists under one roof for the first time. Patients, staff and sight loss charity partners helped select a façade material with less glare and reflection which can be problematic for people with sight loss. The façade panels are manufactured offsite in the Netherlands and installed as complete ‘unitised’ panels.

Facade panels installed - Oriel Over the past month, the exterior of our new centre for eye care, research, and education has started to take shape! The outer part of the building, know as the façade, is made up of a mixture of aluminium, glazing, ribbed terracotta panels with bronze anodised fins. The panels are manufactured off...